<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512003</url>
  </required_header>
  <id_info>
    <org_study_id>HCT6000</org_study_id>
    <nct_id>NCT02512003</nct_id>
  </id_info>
  <brief_title>Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)</brief_title>
  <acronym>FANTOM I</acronym>
  <official_title>Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>REVA Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>REVA Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The FANTOM I pilot study is intended to assess safety of the Fantom Bioresorbable Coronary
      Scaffold in native coronary arteries.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemia-driven Target Lesion Revascularization (TLR)</measure>
    <time_frame>4 months</time_frame>
    <description>Percent of Patients with TLR at 4 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Late Loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Restenosis Rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>% Diameter Stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Minimum Lumen Diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantitative Coronary Angiography (QCA) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Neointimal Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular Ultrasound (IVUS) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Late Loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular Ultrasound (IVUS) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Restenosis Rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular Ultrasound (IVUS) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>% Diameter Stenosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular Ultrasound (IVUS) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Minimum Lumen Diameter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intravascular Ultrasound (IVUS) derived parameters</measure>
    <time_frame>4 months</time_frame>
    <description>Neointimal Volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>12, 24, 36, 48 and 60 months</time_frame>
    <description>Death, Q-Wave Myocardial Infarction, Non Q-Wave Myocardial Infarction (CK-MB &gt; 5x normal), Target Vessel Revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Lesion Revascularization (TLR)</measure>
    <time_frame>12, 24, 36, 48 and 60 months</time_frame>
    <description>Percentage of patients with TLR at each time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel Revascularization</measure>
    <time_frame>12, 24, 36, 48 and 60 months</time_frame>
    <description>Percentage of patients with TVR at each time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target Vessel Failure (TVF)</measure>
    <time_frame>12, 24, 36, 48 and 60 months</time_frame>
    <description>Percentage of patients with TVF at each time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Technical Success</measure>
    <time_frame>Day 0</time_frame>
    <description>Percentage of patients with successful acute delivery and deployment of the device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>30 days</time_frame>
    <description>Percentage of patients with angiographic success (final diameter stenosis &lt;50% without occurrence of MACE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Optical Coherence Tomography (OCT) Imaging on a Subset of Patients</measure>
    <time_frame>4 months</time_frame>
    <description>Qualitative measures in a subset of patients</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Fantom Treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fantom Scaffold</intervention_name>
    <arm_group_label>Fantom Treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has evidence of myocardial ischemia or a positive functional study

          -  Patient has a normal CK-MB

          -  Target lesion has a visually estimated stenosis of ≥50% and &lt;100%

          -  Target lesion is located in a native coronary artery with average reference vessel
             diameter ≥ 2.7mm and ≤ 3.3mm

          -  Target lesion length must be ≤ 14mm

        Exclusion Criteria:

          -  Patient has experienced a myocardial infarction (CK-MB or Troponin &gt; 5 X ULN) within
             72 hours of the procedure

          -  Patient has a left ventricular ejection fraction &lt; 25%

          -  Patient has unprotected lest main coronary disease with ≥50% stenosis

          -  The target vessel is totally occluded (TIMI Flow 0 or 1)

          -  Target lesion involves a bifurcation (a lesion with a side branch ≥ 2.0 mm in diameter
             containing a ≥ 50% stenosis).

          -  Target lesion is located within a bypass graft

          -  Target lesion has possible or definite thrombus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Instituto Dante Pazzanese de Cardiologia</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pracownia Kardiologii Inwazyjnej I Katedry i Kliniki Kardiologii WUM</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2015</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

